drugset / Trial / NCT04470778
Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the effect of gastric pH changes due to famotidine administration on the drug levels of prototype BMS-986256 tablet formulation in healthy participants.
Timeline
- Start
- 2020-07-20
- Primary completion
- 2021-03-21
- Completion
- 2021-03-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Afimetoran | Small molecule | — | — |
| Subject | Famotidine | Other / unclassified | — | — |
Indications
No indication recorded.